Huifang Chen

Chongqing Key Laboratory For Intelligent Oncology In Breast Cancer
Chongqing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Publisher Correction: Early-phase semi-quantitative analysis versus full time-course quantitative modeling of ultrafast dynamic contrast-enhanced MRI for breast cancer diagnosis, molecular subtyping, and treatment response prediction.

Publisher Correction: Early-phase semi-quantitative analysis versus full time-course quantitative modeling of ultrafast dynamic contrast-enhanced MRI for breast cancer diagnosis, molecular subtyping, and treatment response prediction.

Journal: Insights into imaging

Published: March 02, 2026

Pretreatment dual-energy CT versus diffusion-weighted imaging for predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer.

Pretreatment dual-energy CT versus diffusion-weighted imaging for predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer.

Journal: BMC medical imaging

Published: December 03, 2025

Early prediction of pathologic complete response to neoadjuvant chemotherapy based on longitudinal total choline of MR spectroscopy in patients with breast cancer.

Early prediction of pathologic complete response to neoadjuvant chemotherapy based on longitudinal total choline of MR spectroscopy in patients with breast cancer.

Journal: BMC medical imaging

Published: November 16, 2025

APTWI-differential analysis for breast cancer: Association with histopathologic characteristics and early prediction of neoadjuvant chemotherapy response.

APTWI-differential analysis for breast cancer: Association with histopathologic characteristics and early prediction of neoadjuvant chemotherapy response.

Journal: Magnetic resonance imaging

Published: September 03, 2025

Noninvasive stratification of HER2 status in breast cancer using multiparametric DECT: a prospective cohort study.

Noninvasive stratification of HER2 status in breast cancer using multiparametric DECT: a prospective cohort study.

Journal: International journal of surgery (London, England)

Published: August 15, 2025

Fractal analysis of longitudinal MRI for predicting response to neoadjuvant chemotherapy in breast cancer.

Fractal analysis of longitudinal MRI for predicting response to neoadjuvant chemotherapy in breast cancer.

Journal: NPJ precision oncology

Published: July 23, 2025

Comparing Multi-b-Value Diffusion MRI Models for Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.

Comparing Multi-b-Value Diffusion MRI Models for Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.

Journal: Radiology

Published: July 22, 2025

Time-Dependent Diffusion MRI-Based Microstructural Mapping for Characterizing HER2-Zero, -Low, -Ultra-Low, and -Positive Breast Cancer.

Time-Dependent Diffusion MRI-Based Microstructural Mapping for Characterizing HER2-Zero, -Low, -Ultra-Low, and -Positive Breast Cancer.

Journal: Journal of magnetic resonance imaging : JMRI

Published: May 21, 2025

Early-phase semi-quantitative analysis versus full time-course quantitative modeling of ultrafast dynamic contrast-enhanced MRI for breast cancer diagnosis, molecular subtyping, and treatment response prediction.

Early-phase semi-quantitative analysis versus full time-course quantitative modeling of ultrafast dynamic contrast-enhanced MRI for breast cancer diagnosis, molecular subtyping, and treatment response prediction.

Journal: Insights into imaging

Published: May 08, 2025

Nomogram for Predicting Neoadjuvant Chemotherapy Response in Breast Cancer Using MRI-based Intratumoral Heterogeneity Quantification.

Nomogram for Predicting Neoadjuvant Chemotherapy Response in Breast Cancer Using MRI-based Intratumoral Heterogeneity Quantification.

Journal: Radiology

Published: April 15, 2025

Nomograms Integrating MRI-derived Apparent Diffusion Coefficient and Clinicopathologic Features for Prediction of Axillary Lymph Node Metastasis in Breast Cancer.

Nomograms Integrating MRI-derived Apparent Diffusion Coefficient and Clinicopathologic Features for Prediction of Axillary Lymph Node Metastasis in Breast Cancer.

Journal: Radiology. Imaging cancer

Published: March 21, 2025

Time-Dependent Diffusion MRI Helps Predict Molecular Subtypes and Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer.

Time-Dependent Diffusion MRI Helps Predict Molecular Subtypes and Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer.

Journal: Radiology

Published: October 22, 2024

Showing 1-12 of 25

Last Updated: 09/26/2026